Cover Image
市場調查報告書

癌症診斷市場(腫瘤生物標記檢驗、影像、內視鏡、切片檢查) - 全球產業分析、規模、佔有率、成長、趨勢,及預測

Cancer Diagnostics Market (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

出版商 Transparency Market Research 商品編碼 318871
出版日期 內容資訊 英文 124 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
癌症診斷市場(腫瘤生物標記檢驗、影像、內視鏡、切片檢查) - 全球產業分析、規模、佔有率、成長、趨勢,及預測 Cancer Diagnostics Market (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
出版日期: 2014年10月31日 內容資訊: 英文 124 Pages
簡介

本報告提供癌症診斷市場現狀與到2020年的預測、各市場區隔趨勢、各地區趨勢,及打入市場的主要企業簡介彙整。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和概要
  • 各種癌症的風險係數、預後、復發
    • 風險係數
    • 復發和預後
    • 市場趨勢和未來發展預測
    • 法律規章方案
  • 市場趨勢
    • 推動市場的要素
    • 阻礙市場的要素
    • 機會
  • 波特五力分析
  • 活動影響分析
  • 市場魅力度
  • 競爭環境

第4章 各手法市場

  • 概要
  • 腫瘤生物標記檢驗
  • 影像
  • 內視鏡
  • 切片檢查

第5章 各用途市場

  • 概要
  • 血液癌症
  • 乳癌
  • 大腸癌
  • 腎臟癌
  • 肝癌症
  • 肺癌
  • 卵巢癌
  • 胰臟癌
  • 前列腺癌

第6章 各地區市場

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第7章 企業簡介

  • Abbott Laboratories, Inc.
  • Ambry Genetics
  • AstraZeneca plc
  • bioMeriux SA
  • Eli Lilly and Company
  • Genoptix, Inc.
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd.
  • Pfizer, Inc.

圖表

目錄

This report on cancer diagnostics analyzes the current as well as future prospects of various facets of the market in detail. It provides an in-depth and comprehensive analysis of the cancer diagnostics market. The report includes an elaborate executive summary, which covers a market snapshot representing key findings from the study for various segments such as diagnostic methods, applications, and geography (North America, Europe, Asia-Pacific and Rest of the World).

For the research on this topic, we conducted in-depth interviews and discussions with a wide range of key opinion leaders within cancer diagnostics market, which was supplemented by extensive secondary research. The report provides market size in terms of USD million for each segment for the period 2012 to 2020, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall cancer diagnostics market and the segments has also been provided in the report for the forecast period 2014 to 2020, considering 2012 and 2013 as the base years. Growth rates for each segment within the cancer diagnostics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

The global cancer diagnostics market is categorized based on the diagnostic methods into four major segments, namely, tumor biomarker tests, imaging, endoscopy, and biopsy. The market analysis provided for tumor biomarker tests include revenue from major cancer biomarker tests such as prostate specific antigen (PSA) tests, human epidermal growth factor receptor 2 (HER2) tests, circulating tumor cells (CTC) tests , carcinoembryonic antigen (CEA) test, anaplastic lymphoma kinase (ALK) test, BRCA gene tests, and other tests such as AFP, CA 19-9, CA 125 tests. The report also provides market size for imaging procedures for cancer diagnostics, namely, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), x-ray and ultrasound imaging. The market size estimation for endoscopies such as colonoscopy, sigmoidoscopy, bronchoscpopy and colposcopy; and biopsies such as bone marrow biopsy, needle biopsy and endoscopic biopsy are provided in the report.

The cancer diagnostics market has been further analyzed for applications such as cancer of lung, breast, colorectal, prostate, liver, blood, and others (cancers of kidney, pancreas, and ovary). According to our estimates, in 2013, lung cancer accounted for the largest share in the global cancer diagnostics market and is expected to continue to grow in the near future. On the basis of geography, the overall global cancer diagnostics market has been segmented into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The research study also incorporates a qualitative analysis of the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the cancer diagnostics market and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis and Porter's five forces analysis. In addition, the study also provides insights into the competitive landscape of the global cancer diagnostics market.

The study is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interaction via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases for patents, clinical trials, demographics, disease incidence/prevalence, etc. The report also profiles major players in the cancer diagnostics market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players covered in this report are Abbott Laboratories, Ambry Genetics, AstraZeneca plc, bioMerieux SA, Eli Lilly and Company, Genoptix (A Novartis Company), GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd. and Pfizer, Inc.

The global cancer diagnostics market is segmented as follows:

Cancer Diagnostics Market, by Method

  • Tumor Biomarker Tests
    • PSA Tests
    • CTC Tests
    • AFP Tests
    • CA 19-9
    • CA 125
    • EGFR
    • HER2
    • CEA
    • BRCA
    • KRAS
    • ALK
  • Imaging
    • MRI Scan
    • PET Scan
    • CT Scan
    • Mammography
    • Ultrasound
  • Endoscopy
    • Bronchoscopy
    • Colonoscopy
    • Sigmoidoscopy
    • Colposcopy
    • Others
  • Biopsy
    • Bone Marrow Biopsy
    • Needle Biopsy
    • Endoscopic Biopsy

Cancer Diagnostics Market, by Application

  • Leukemia
  • Breast Cancer
  • Colorectal Cancer
  • Kidney
  • Liver
  • Lung
  • Ovarian
  • Pancreatic
  • Prostate

Cancer Diagnostics Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
  • 1.3.1 Assumptions and Stipulations
  • 1.4 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Global Cancer Diagnostics Market, by Application, 2013 (USD Million)
  • 2.2 Comparative Analysis: Global Cancer Diagnostics Market, By Geography, 2013 & 2020 (Value %)

Chapter 3 Market Overview

  • 3.1 Market Definition and Overview
  • 3.2 Risk Factors, Prognosis and Recurrence of Different Cancers
    • 3.2.1 Risk Factors
    • 3.2.2 Recurrence and Prognosis of Cancer
    • 3.2.3 Market Trends and Future Outlook
    • 3.2.4 Regulatory Scenario
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Rising Prevalence of Cancer Drives Demand for Cancer Diagnostics
      • 3.3.1.2 Early Diagnosis Crafts Better Clinical and Economical Outcomes
      • 3.3.1.3 Novel Diagnostic Biomarkers Continues To Create New Revenue Stream
    • 3.3.2 Market Restraints
      • 3.3.2.1 Lack of Sensitivity and Specificity
      • 3.3.2.2 Uncertain Reimbursement Scenario Limits Market Growth
    • 3.3.3 Opportunity
      • 3.3.3.1 Introduction of Non-invasive and Safe Cancer Screening Methods
  • 3.4 Porter's Five Force Analysis
    • 3.4.1 Bargaining Power of Buyers
    • 3.4.2 Bargaining Power of Suppliers
    • 3.4.3 Threat of New Entrants
    • 3.4.4 Threat of Substitutes
    • 3.4.5 Competitive Rivalry
  • 3.5 Event Impact Analysis
  • 3.6 Market Attractiveness
    • 3.6.1 Market Attractiveness Analysis: Global Cancer Diagnostics Market, By Method, 2013 & 2020 (Value %)
  • 3.7 Competitive Landscape
    • 3.7.1 Cancer Diagnostics Market: Global Market Share by Key Players, IVDs, Molecular Diagnostics and Companion Diagnostics), 2013 (Value %)
    • 3.7.2 Cancer Diagnostics Market: Global Market Share by Key Players (Imaging Equipment Manufacturers), 2013 (Value %)

Chapter 4 Global Cancer Diagnostics Market, by Methods

  • 4.1 Overview
    • 4.1.1 Global Cancer Diagnostics Market Revenue, by Method, 2012-2020 (USD Million)
    • 4.1.2 Comparative analysis: Global Cancer Diagnostics Market, by Methods, 2013 & 2020 (Value %)
  • 4.2 Tumor Biomarker Tests
    • 4.2.1 Prostate Specific Antigen Tests
      • 4.2.1.1 Global Prostate Specific Antigen Tests Market Revenue, 2012-2020 (USD Million)
    • 4.2.2 Circulating Tumor Cells (CTC) Tests
      • 4.2.2.1 Global Circulating Tumor Cells (CTC) Tests Market Revenue, 2012-2020 (USD Million)
    • 4.2.3 Alpha-Fetoprotein (AFP) Tests
      • 4.2.3.1 Global Alpha-Fetoprotein (AFP) Tests Market Revenue, 2012-2020 (USD Million)
    • 4.2.4 CA 19-9 Tests
      • 4.2.4.1 Global CA 19-9 Tests Market Revenue, 2012-2020 (USD Million)
    • 4.2.5 CA 125 Tests
      • 4.2.5.1 Global CA 125 Tests Market Revenue, 2012-2020 (USD Million)
    • 4.2.6 EGFR Mutation Tests
      • 4.2.6.1 Global EGFR Mutation Tests Market Revenue, 2012-2020 (USD Million)
    • 4.2.7 HER2 Tests
      • 4.2.7.1 Global HER2 Tests Market Revenue, 2012-2020 (USD Million)
    • 4.2.8 Carcinoembryonic Antigen (CEA) Tests
      • 4.2.8.1 Global Carcinoembryonic Antigen (CEA) Tests Market Revenue, 2012-2020 (USD Million)
    • 4.2.9 BRCA Tests
      • 4.2.9.1 Global BRCA Tests Market Revenue, 2012-2020 (USD Million)
    • 4.2.10 KRAS Mutation Tests
      • 4.2.10.1 Global KRAS Mutation Tests Market Revenue, 2012-2020 (USD Million)
    • 4.2.11 Anaplastic Lymphoma Kinase (ALK) Tests
      • 4.2.11.1 Global Anaplastic Lymphoma Kinase (ALK) Tests Market Revenue, 2012-2020 (USD Million)
  • 4.3 Imaging
    • 4.3.1 Magnetic Resonance Imaging (MRI) Scan
      • 4.3.1.1 MRI Scan Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
    • 4.3.2 Positron Emission Tomography (PET) Scan
      • 4.3.2.1 PET Scan Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)
    • 4.3.3 Computed Tomography (CT) Scan
      • 4.3.3.1 CT Scan Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)
    • 4.3.4 Mammography
      • 4.3.4.1 Mammography Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)
    • 4.3.5 Ultrasound
      • 4.3.5.1 Ultrasound Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)
  • 4.4 Endoscopy
    • 4.4.1 Colonoscopy
      • 4.4.1.1 Global Colonoscopy Tests Market Revenue, 2012-2020 (USD Million)
    • 4.4.2 Sigmoidoscopy
      • 4.4.2.1 Global Sigmoidoscopy Tests Market Revenue, 2012-2020 (USD Million)
    • 4.4.3 Bronchoscopy
      • 4.4.3.1 Global Bronchoscopy Tests Market Revenue, 2012-2020 (USD Million)
    • 4.4.4 Colposcopy
      • 4.4.4.1 Global Colposcopy Tests Market Revenue, 2012-2020 (USD Million)
    • 4.4.5 Other Endoscopy
      • 4.4.5.1 Global Other Endoscopy Tests Market Revenue, 2012-2020 (USD Million)
  • 4.5 Biopsy
    • 4.5.1 Bone Marrow Biopsy
      • 4.5.1.1 Global Bone Marrow Biopsy Tests Market Revenue, 2012-2020 (USD Million)
    • 4.5.2 Needle Biopsy
      • 4.5.2.1 Global Needle Biopsy Tests Market Revenue, 2012-2020 (USD Million)
    • 4.5.3 Endoscopic Biopsy
      • 4.5.3.1 Global Endoscopic Biopsy Tests Market Revenue, 2012-2020 (USD Million)

Chapter 5 Global Cancer Diagnostics Market, by Applications

  • 5.1 Overview
    • 5.1.1 Global Cancer Diagnostics Market Revenue, by Applications Geography, 2012-2020 (USD) Million
    • 5.1.2 Comparative analysis: Global Cancer Diagnostics Market, by Applications, 2013 & 2020 (Value %)
  • 5.2 Blood Cancer
    • 5.2.1 Blood Cancer: Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)
    • 5.2.2 Global Blood Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • 5.3 Breast Cancer
    • 5.3.1 Breast Cancer: Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)
    • 5.3.2 Global Breast Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • 5.4 Colorectal Cancer (CRC)
    • 5.4.1 Colorectal Cancer: Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)
    • 5.4.2 Global Colorectal Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • 5.5 Kidney Cancer
    • 5.5.1 Kidney Cancer : Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)
    • 5.5.2 Global Kidney Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • 5.6 Liver Cancer
    • 5.6.1 Liver Cancer : Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)
    • 5.6.2 Global Liver Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • 5.7 Lung Cancer
    • 5.7.1 Lung Cancer : Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)
    • 5.7.2 Global Lung Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • 5.8 Ovarian Cancer
    • 5.8.1 Ovarian Cancer : Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)
    • 5.8.2 Global Ovarian Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • 5.9 Pancreatic Cancer
    • 5.9.1 Pancreatic Cancer : Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)
    • 5.9.2 Global Pancreatic Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • 5.10 Prostate Cancer
    • 5.10.1 Prostate Cancer : Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)
    • 5.10.2 Global Prostate Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

Chapter 6 Global Cancer Diagnostics Market, by Geography

  • 6.1 Overview
    • 6.1.1 Global Cancer Diagnostics Market Revenue, by Geography, 2012-2020 (USD) Million
    • 6.1.2 Comparative Analysis: Global Cancer Diagnostics Market by Geography, 2013 & 2020 (Value %)
  • 6.2 North America
    • 6.2.1 North America Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • 6.5 Rest of the World (RoW)
    • 6.5.1 Rest of the World Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Abbott Laboratories, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Product Portfolio
    • 7.1.4 Business Strategies
    • 7.1.5 Recent Developments
  • 7.2 Ambry Genetics
    • 7.2.1 Company Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Product Portfolio
    • 7.2.4 Business Strategies
    • 7.2.5 Recent Developments
  • 7.3 AstraZeneca plc
    • 7.3.1 Company Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Product Portfolio
    • 7.3.4 Business Strategies
    • 7.3.5 Recent Developments
  • 7.4 bioMeriux SA
    • 7.4.1 Company Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Product Portfolio
    • 7.4.4 Business Strategies
    • 7.4.5 Recent Developments
  • 7.5 Eli Lilly and Company
    • 7.5.1 Company Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Product Portfolio
    • 7.5.4 Business Strategies
    • 7.5.5 Recent Developments
  • 7.6 Genoptix, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Product Portfolio
    • 7.6.4 Business Strategies
    • 7.6.5 Recent Developments
  • 7.7 GlaxoSmithKline plc
    • 7.7.1 Company Overview
    • 7.7.2 Financial Overview
    • 7.7.3 Product Portfolio
    • 7.7.4 Business Strategies
    • 7.7.5 Recent Developments
  • 7.8 F. Hoffmann-La Roche Ltd.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Overview
    • 7.8.3 Product Portfolio
    • 7.8.4 Business Strategies
    • 7.8.5 Recent Developments
  • 7.9 Pfizer, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Overview
    • 7.9.3 Product Portfolio
    • 7.9.4 Business Strategies
    • 7.9.5 Recent Developments

List of Figures

  • FIG. 1 Global and U.S. Cancer Biomarker Blood Tests Market Segmentation
  • FIG. 2 Global Cancer Diagnostics Market, by Application, 2013 (USD Million)
  • FIG. 3 Comparative Analysis: Global Cancer Diagnostics Market, by Geography, 2013 & 2020E (Value %)
  • FIG. 4 Porter's Five Forces Analysis: Global Cancer Diagnostics Market
  • FIG. 5 Market Attractiveness Analysis: Global Cancer Diagnostics Market, By Method, 2013 & 2020 (Value %)
  • FIG. 6 Cancer Diagnostics Market: Global Market Share by Key Players, IVDs, Molecular Diagnostics and Companion Diagnostics), 2013 (Value %)
  • FIG. 7 Cancer Diagnostics Market: Global Market Share by Key Players, 2013 (Value %)
  • FIG. 8 Comparative analysis: Global Cancer Diagnostics Market, by Methods, 2013 & 2020 (Value %)
  • FIG. 9 Global Prostate Specific Antigen Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 10 Global Circulating Tumor Cells (CTC) Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 11 Global Alpha-Fetoprotein (AFP) Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 12 Global CA 19-9 Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 13 Global CA 19-9 Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 14 Global EGFR Mutation Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 15 Global HER2 Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 16 Global Carcinoembryonic Antigen (CEA) Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 17 Global BRCA Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 18 Global KRAS Mutation Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 19 Global Anaplastic Lymphoma Kinase (ALK) Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 20 MRI Scan Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)
  • FIG. 21 PET Scan Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)
  • FIG. 22 CT Scan Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)
  • FIG. 23 Mammography Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)
  • FIG. 24 Ultrasound Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)
  • FIG. 25 Global Colonoscopy Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 26 Global Sigmoidoscopy Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 27 Global Bronchoscopy Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 28 Global Colposcopy Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 29 Global Other Endoscopy Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 30 Global Bone Marrow Biopsy Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 31 Global Needle Biopsy Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 32 Global Endoscopic Biopsy Tests Market Revenue, 2012-2020 (USD Million)
  • FIG. 33 Comparative analysis: Global Cancer Diagnostics Market, by Applications, 2013 & 2020 (Value %)
  • FIG. 34 Blood Cancer: Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)
  • FIG. 35 Global Blood Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • FIG. 52 Comparative Analysis: Global Cancer Diagnostics Market, By Geography, 2013 & 2020 (Value %)
  • FIG. 53 North America Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • FIG. 54 Europe Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • FIG. 55 Asia Pacific Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • FIG. 56 Asia Pacific Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)
  • FIG. 57 Abbott Laboratories : Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 58 Astra Zeneca plc: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 59 bioMeriux SA : Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 60 Eli Lilly and Company: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 61 GlaxoSmithKline plc: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 62 F. Hoffmann-La Roche Ltd: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 63 Pfizer, Inc.: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 List of Abbreviation
  • TABLE 2 Market Snapshot: Global Cancer Diagnostics Market
  • TABLE 3 List of Cancer Risk Factors
  • TABLE 4 Estimated Incidence, and 1 year, 2 years and 5 years survival
  • TABLE 5 Breast Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs
  • TABLE 6 Lung Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs
  • TABLE 7 Colorectal Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs
  • TABLE 8 Summary of Type of Diagnostics Test in the U.S.
  • TABLE 9 Event Impact Analysis: Global Cancer Diagnostics Market, 2012-2020
  • TABLE 10 Global Cancer Diagnostics Market Revenue, by Method, 2012-2020 (USD) Million
  • TABLE 11 Global Cancer Diagnostics Market Revenue, by Applications, 2012-2020 (USD) Million
  • TABLE 12 Global Cancer Diagnostics Market Revenue, by Geography, 2012-2020 (USD) Million
Back to Top